ARCHIVES

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

ACS Funds $54 Million in Grants

June 28, 2002

DCCP Board Okays New Projects In Chemoprevention, Other Programs Totaling $5 Million In First Year

December 14, 1979

FDA Proposes Guidelines For Testing New Anticancer Drugs

November 14, 1975

Tobacco Control: Cigarette Consumption In ASSIST States 10% Below Other States

January 17, 1997

Healy’s Boxes Packed, When Word Came That She Could Stay

January 29, 1993

RFA: Native American Women’s Cancer Initiative

July 9, 1993